The US ECMO machine market revenue trajectory is on a consistent rise, starting at $400 million in 2020, increasing to $600 million in 2025, and forecasted to reach $1,250 million by 2035. Growth is fueled by expanding awareness, higher adoption in diverse care settings, and continual technological innovation by market leaders. The increased demand for critical care devices and successful integration of ECMO into advanced cardiopulmonary support protocols play pivotal roles. This revenue progression underscores not only expanding utilization but also reflects the impact of favorable reimbursement, ongoing clinical studies, and broadening indications for ECMO therapy in the US.

Read More - https://bussinessinsights.com/research-report/us-extracorporeal-membrane-oxygenation-machine

Within the US ECMO machine market by 2025, the dominant application segment remains respiratory indications, which capture the highest share due to surging cases of ARDS attributed to infections and chronic illnesses. Cardiac applications follow closely, propelled by an increasing incidence of advanced heart failure, post-cardiotomy support, and ECPR deployment in critical care. The ECPR segment, while smaller, is gaining traction as healthcare providers recognize its life-saving benefits during cardiac arrest scenarios where conventional resuscitation fails. The distribution of shares reflects the ongoing prioritization of life-threatening respiratory and cardiac scenarios in US healthcare delivery and greater availability of specialized ECMO teams in major hospitals.

Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-extracorporeal-membrane-oxygenation-machine

Frequently Asked Questions

Who are the key players in US Extracorporeal Membrane Oxygenation Machine industry?
The top five players in the US Extracorporeal Membrane Oxygenation (ECMO) machine market are Getinge AB, Medtronic, Abbott Laboratories, Terumo Corporation, and Fresenius Medical Care. These companies are recognized for technological innovation, comprehensive product portfolios, and strong distribution networks dedicated to supporting advanced cardiopulmonary critical care solutions.

What is the US Extracorporeal Membrane Oxygenation Machine growth?
The US ECMO machine market has experienced significant growth, particularly post-COVID-19, with demand fueled by increased incidence of severe respiratory failure. Companies like Getinge AB reported notable revenue increases in 2023 as hospitals expand capacities for advanced life-support equipment.

Which segment accounted for the largest US Extracorporeal Membrane Oxygenation Machine share?
The largest US ECMO machine market share is held by the respiratory application segment. The demand is attributed to rising cases of acute respiratory distress syndrome (ARDS) and other severe lung conditions, where ECMO serves as an essential lifesaving intervention in critical care settings.

Thanks & Regards,
Manisha C
sales@bussinessinsights.com